⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL852140 | 0.82 | — | — | |
| SCHEMBL852141 | 0.82 | — | — | |
| SCHEMBL19661047 | 0.82 | — | — | |
| SCHEMBL852156 | 0.82 | — | — | |
| SCHEMBL16615842 | 0.75 | — | — | |
| SCHEMBL17029292 | 0.75 | — | — | |
| SCHEMBL18600034 | 0.75 | — | — | |
| SCHEMBL10504642 | 0.75 | — | — | |
| SCHEMBL12330201 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL19221189 | 0.75 | TDP1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030081-B2 | Large lateral scale two-dimensional materials and other thin films, and associated systems and methods | THE UNIVERSITY OF CHICAGO (US) | 2024-07-09 | — | — | US | disclosed |
| US-20220388026-A1 | LARGE LATERAL SCALE TWO-DIMENSIONAL MATERIALS AND OTHER THIN FILMS, AND ASSOCIATED SYSTEMS AND METHODS | THE UNIVERSITY OF CHICAGO (US) | 2022-12-08 | — | — | US | disclosed |
| US-9233057-B2 | Particular quinone direct dyes, dye composition comprising at least one such dye, implementation process therefor and use thereof | L'OREAL (FR) | 2016-01-12 | — | — | US | disclosed |
| US-20140360523-A1 | PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF | L'OREAL (FR) | 2014-12-11 | — | — | US | disclosed |
| WO-2012027261-A1 | SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | AMGEN INC. (US) | 2012-03-01 | — | — | WO | disclosed |
| US-20100048561-A1 | QUINAZOLINES FOR PDK1 INHIBITION | NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) | 2010-02-25 | — | — | US | disclosed |